ReShape Lifesciences Inc. (RSLS)
USD 0.38
(-15.62%)
USD 0.38
(-15.62%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -14.48 Million USD | 41.86% |
| 2022 | -24.92 Million USD | 10.22% |
| 2021 | -60.61 Million USD | -122.76% |
| 2020 | -18.09 Million USD | 27.68% |
| 2019 | -17.22 Million USD | 28.57% |
| 2018 | -36.96 Million USD | 23.23% |
| 2017 | -34.39 Million USD | -37.81% |
| 2016 | -19.5 Million USD | 24.62% |
| 2015 | -27.67 Million USD | -20.66% |
| 2014 | -25.4 Million USD | -5.78% |
| 2013 | -24.55 Million USD | -5.05% |
| 2012 | -22.32 Million USD | 9.52% |
| 2011 | -24.92 Million USD | -66.07% |
| 2010 | -15 Million USD | 9.02% |
| 2009 | -16.49 Million USD | 53.84% |
| 2008 | -35.73 Million USD | -34.46% |
| 2007 | -26.57 Million USD | -47.39% |
| 2006 | -18.03 Million USD | -63.66% |
| 2005 | -11.01 Million USD | -219.46% |
| 2004 | -3.44 Million USD | -81.42% |
| 2003 | -1.9 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.21 Million USD | -16.74% |
| 2024 Q2 | -2.04 Million USD | 7.08% |
| 2023 Q3 | -3.1 Million USD | 30.5% |
| 2023 Q2 | -4.46 Million USD | 20.68% |
| 2023 Q1 | -5.62 Million USD | 53.0% |
| 2023 FY | - USD | 41.86% |
| 2023 Q4 | -1.88 Million USD | 39.16% |
| 2022 Q1 | -7.86 Million USD | -15.59% |
| 2022 Q2 | -7.73 Million USD | 1.69% |
| 2022 FY | - USD | 10.22% |
| 2022 Q4 | -11.97 Million USD | -454.24% |
| 2022 Q3 | 3.38 Million USD | 143.72% |
| 2021 Q2 | -3.25 Million USD | -76.84% |
| 2021 Q1 | -1.83 Million USD | 42.64% |
| 2021 Q3 | -14.43 Million USD | -343.91% |
| 2021 Q4 | -6.8 Million USD | 52.86% |
| 2021 FY | - USD | -122.76% |
| 2020 Q1 | -3.66 Million USD | -118.26% |
| 2020 FY | - USD | 27.68% |
| 2020 Q3 | -2.17 Million USD | 15.85% |
| 2020 Q4 | -3.2 Million USD | -47.61% |
| 2020 Q2 | -2.58 Million USD | 29.48% |
| 2019 Q3 | -4.42 Million USD | 12.88% |
| 2019 Q2 | -5.07 Million USD | -37.85% |
| 2019 FY | - USD | 28.57% |
| 2019 Q4 | 20.04 Million USD | 553.22% |
| 2019 Q1 | -3.68 Million USD | -175.6% |
| 2018 Q3 | -6.73 Million USD | 27.32% |
| 2018 FY | - USD | 23.23% |
| 2018 Q1 | -11.85 Million USD | 0.66% |
| 2018 Q2 | -9.27 Million USD | 21.75% |
| 2018 Q4 | 4.87 Million USD | 172.29% |
| 2017 Q1 | -7.01 Million USD | -69.83% |
| 2017 Q3 | -1.03 Million USD | 84.92% |
| 2017 Q2 | -6.86 Million USD | 2.07% |
| 2017 Q4 | -11.92 Million USD | -1051.52% |
| 2017 FY | - USD | -37.81% |
| 2016 Q4 | -4.12 Million USD | 7.47% |
| 2016 FY | - USD | 24.62% |
| 2016 Q2 | -6.65 Million USD | 11.25% |
| 2016 Q1 | -7.5 Million USD | 9.99% |
| 2016 Q3 | -4.46 Million USD | 32.95% |
| 2015 Q1 | -6.96 Million USD | -16.2% |
| 2015 Q4 | -8.33 Million USD | -39.79% |
| 2015 Q3 | -5.96 Million USD | 18.25% |
| 2015 Q2 | -7.29 Million USD | -4.71% |
| 2015 FY | - USD | -20.66% |
| 2014 Q1 | -6.38 Million USD | -3.38% |
| 2014 Q2 | -7.3 Million USD | -14.44% |
| 2014 Q4 | -5.99 Million USD | -8.06% |
| 2014 Q3 | -5.54 Million USD | 24.09% |
| 2014 FY | - USD | -5.78% |
| 2013 Q1 | -6.05 Million USD | 10.41% |
| 2013 Q2 | -5.81 Million USD | 3.93% |
| 2013 Q3 | -5.63 Million USD | 3.13% |
| 2013 Q4 | -6.17 Million USD | -9.54% |
| 2013 FY | - USD | -5.05% |
| 2012 Q1 | -5.41 Million USD | 30.52% |
| 2012 Q3 | -5.29 Million USD | -17.6% |
| 2012 Q4 | -6.76 Million USD | -27.59% |
| 2012 Q2 | -4.5 Million USD | 16.77% |
| 2012 FY | - USD | 9.52% |
| 2011 Q1 | -4.78 Million USD | -37.61% |
| 2011 Q2 | -5.2 Million USD | -8.88% |
| 2011 Q3 | -6.96 Million USD | -33.87% |
| 2011 Q4 | -7.79 Million USD | -11.83% |
| 2011 FY | - USD | -66.07% |
| 2010 Q3 | -3.8 Million USD | 9.45% |
| 2010 FY | - USD | 9.02% |
| 2010 Q1 | -4.21 Million USD | 27.08% |
| 2010 Q2 | -4.19 Million USD | 0.36% |
| 2010 Q4 | -3.47 Million USD | 8.65% |
| 2009 FY | - USD | 53.84% |
| 2009 Q4 | -5.78 Million USD | -129.02% |
| 2009 Q1 | 1.41 Million USD | 122.2% |
| 2009 Q2 | -2.1 Million USD | -248.59% |
| 2009 Q3 | -2.52 Million USD | -19.79% |
| 2008 Q4 | -6.38 Million USD | 36.53% |
| 2008 Q1 | -8.27 Million USD | 1.33% |
| 2008 Q2 | -10.97 Million USD | -32.51% |
| 2008 Q3 | -10.06 Million USD | 8.24% |
| 2008 FY | - USD | -34.46% |
| 2007 Q1 | -6.6 Million USD | -26.51% |
| 2007 Q3 | -6.32 Million USD | 4.28% |
| 2007 FY | - USD | -47.39% |
| 2007 Q4 | -8.39 Million USD | -32.62% |
| 2007 Q2 | -6.6 Million USD | 0.0% |
| 2006 FY | - USD | -63.66% |
| 2006 Q2 | -4.15 Million USD | 0.0% |
| 2006 Q4 | -5.22 Million USD | -25.74% |
| 2006 Q3 | -4.15 Million USD | 0.0% |
| 2006 Q1 | -4.15 Million USD | -48.2% |
| 2005 Q2 | -2.8 Million USD | 0.0% |
| 2005 FY | - USD | -219.46% |
| 2005 Q1 | -2.8 Million USD | 0.0% |
| 2005 Q4 | -2.8 Million USD | 0.0% |
| 2005 Q3 | -2.8 Million USD | 0.0% |
| 2004 FY | - USD | -81.42% |
| 2003 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -7.4% |
| Cerus Corporation | -26.53 Million USD | 45.414% |
| OrthoPediatrics Corp. | -8.38 Million USD | -72.831% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -38.025% |
| Talis Biomedical Corporation | -66.04 Million USD | 78.068% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 13.133% |
| Inogen, Inc. | -45.67 Million USD | 68.29% |
| Spectral AI, Inc. | -12.26 Million USD | -18.129% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 69.629% |
| CVRx, Inc. | -38.73 Million USD | 62.601% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -310.573% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -19.642% |
| Orthofix Medical Inc. | -86.98 Million USD | 83.348% |
| Venus Concept Inc. | -26.11 Million USD | 44.53% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 70.897% |
| Bioventus Inc. | -23.07 Million USD | 37.213% |
| BrainsWay Ltd. | -2.31 Million USD | -526.785% |
| Envoy Medical, Inc. | -18.23 Million USD | 20.578% |
| electroCore, Inc. | -17.76 Million USD | 18.44% |
| IceCure Medical Ltd | -15.25 Million USD | 5.035% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 70.885% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 14.065% |
| MaxCyte, Inc. | -44.12 Million USD | 67.175% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -23.214% |
| Nexalin Technology, Inc. | -5.69 Million USD | -154.478% |
| PAVmed Inc | -75.74 Million USD | 80.876% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 73.055% |
| RxSight, Inc. | -41.03 Million USD | 64.703% |
| Sight Sciences, Inc. | -49.41 Million USD | 70.687% |
| SI-BONE, Inc. | -34.44 Million USD | 57.949% |
| TELA Bio, Inc. | -40.63 Million USD | 64.352% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 75.154% |
| Treace Medical Concepts, Inc. | -39 Million USD | 62.867% |
| LivaNova PLC | 39.01 Million USD | 137.126% |
| 908 Devices Inc. | -34.02 Million USD | 57.428% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 86.902% |
| Nemaura Medical Inc. | -7.28 Million USD | -98.777% |
| NeuroPace, Inc. | -22.83 Million USD | 36.564% |
| LENSAR, Inc. | -8.71 Million USD | -66.227% |
| Apyx Medical Corporation | -18.11 Million USD | 20.025% |
| Cutera, Inc. | -136.56 Million USD | 89.393% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -328.55% |
| BioSig Technologies, Inc. | -28.15 Million USD | 48.545% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 675.715% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 30.988% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 103.776% |
| Axonics, Inc. | 7.77 Million USD | 286.302% |
| Outset Medical, Inc. | -153.78 Million USD | 90.581% |
| IRIDEX Corporation | -7.44 Million USD | -94.482% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 85.234% |
| IRadimed Corporation | 20.8 Million USD | 169.637% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -79.67% |
| INVO Bioscience, Inc. | -6.88 Million USD | -110.537% |
| Telesis Bio, Inc. | -40.49 Million USD | 64.228% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 139.493% |
| Varex Imaging Corporation | 67.2 Million USD | 121.555% |
| Quipt Home Medical Corp. | 44.07 Million USD | 132.867% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -33.257% |
| Pulmonx Corporation | -55.09 Million USD | 73.708% |
| Dynatronics Corporation | -976 Thousand USD | -1384.107% |
| Modular Medical, Inc. | -17.1 Million USD | 15.307% |
| Semler Scientific, Inc. | 23.58 Million USD | 161.406% |
| InMode Ltd. | 196.28 Million USD | 107.38% |
| Bruker Corporation | 599 Million USD | 102.418% |
| Cytosorbents Corporation | -28.81 Million USD | 49.724% |
| DexCom, Inc. | 916.7 Million USD | 101.58% |
| Align Technology, Inc. | 799.03 Million USD | 101.813% |
| Viveve Medical, Inc. | -20.61 Million USD | 29.742% |
| ZimVie Inc. | 91.07 Million USD | 115.905% |
| Movano Inc. | -29.12 Million USD | 50.266% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -228.607% |
| Nexalin Technology, Inc. | -5.69 Million USD | -154.478% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -310.573% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 92.559% |
| Profound Medical Corp. | -27.12 Million USD | 46.596% |
| Insulet Corporation | 323.6 Million USD | 104.476% |
| enVVeno Medical Corporation | -25.01 Million USD | 42.102% |
| Surmodics, Inc. | 1.18 Million USD | 1319.276% |
| iCAD, Inc. | -6.56 Million USD | -120.64% |
| Nuwellis, Inc. | -16.35 Million USD | 11.439% |
| Biotricity, Inc. | -8.82 Million USD | -64.075% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 85.046% |
| Aethlon Medical, Inc. | -11.84 Million USD | -22.245% |
| InspireMD, Inc. | -20.91 Million USD | 30.73% |
| PAVmed Inc. | -75.74 Million USD | 80.876% |
| BIOLASE, Inc. | -15.13 Million USD | 4.32% |
| Beyond Air, Inc. | -59.03 Million USD | 75.462% |
| FONAR Corporation | 28.25 Million USD | 151.271% |
| AxoGen, Inc. | -13.32 Million USD | -8.681% |
| Vivani Medical, Inc. | -26.6 Million USD | 45.561% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 159.024% |
| Inari Medical, Inc. | 7.11 Million USD | 303.641% |
| UFP Technologies, Inc. | 72.74 Million USD | 119.913% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -327.818% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -135.299% |
| Tenon Medical, Inc. | -15.52 Million USD | 6.717% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 5.116% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 65.076% |
| AdaptHealth Corp. | -171.09 Million USD | 91.534% |
| Sintx Technologies, Inc. | -6.6 Million USD | -119.47% |
| NanoVibronix, Inc. | -3.43 Million USD | -321.689% |
| Quanterix Corporation | -38.08 Million USD | 61.97% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -33.257% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 48383.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 94.776% |
| TransMedics Group, Inc. | -7.6 Million USD | -90.517% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 33.448% |
| NeuroMetrix, Inc. | -7.09 Million USD | -104.135% |
| Hyperfine, Inc. | -47.06 Million USD | 69.221% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 75.157% |
| Biomerica, Inc. | -5.99 Million USD | -141.699% |
| Bone Biologics Corporation | 479.57 Thousand USD | 3120.402% |
| AVITA Medical, Inc. | -39.56 Million USD | 63.392% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -57.91% |
| Silk Road Medical, Inc | -45.08 Million USD | 67.868% |